Home › Cases › Cardiogenic Shock
Acute Heart Failure
Cardiogenic Shock
6 questions
Question 1 · Cardiogenic shock recognition
Correct answer: Cardiogenic shock — pump failure post-MI. Defined by hypotension + hypoperfusion despite adequate preload
Why
Cardiogenic shock is cardiac pump failure with hypoperfusion: cold peripheries, oliguria, confusion or raised lactate. SBP<90 is a common sign; do not wait 30 minutes to escalate this patient. Check filling and reversible causes. Short-term mortality is commonly 30–50%, higher in severe shock.
Key point
Hypotension + cold peripheries, oliguria or confusion after MI: call cardiology/ICU now. Mortality is high—commonly 30–50%, worse with severe shock.
Question 2 · Fluids in cardiogenic shock
Correct answer: Small fluid challenge (250-500ml) only if evidence of hypovolaemia. Most cardiogenic shock has adequate/high filling pressures — fluids worsen pulmonary oedema
Why
Fluids in cardiogenic shock: preload is often already high (raised filling pressures → pulmonary oedema). Large fluid boluses worsen LV overload and gas exchange. However, some patients have relative hypovolaemia (post-PPCI, diuretics). Small challenge (250ml) with reassessment, or guided by invasive monitoring (CVP, Swan-Ganz).
Key point
Cardiogenic shock: NOT fluid boluses (worsens pulmonary oedema). Small challenges if hypovolaemic. Invasive monitoring.
Question 3 · Inotropes and vasopressors
Correct answer: Noradrenaline (vasopressor — maintains BP), with dobutamine if low output persists (inotrope — improves contractility). Avoid high-dose adrenaline alone
Why
Cardiogenic shock vasoactive therapy: noradrenaline (vasopressor — supports BP/perfusion; MAP around 65 is a common initial goal, adjusted clinically) with dobutamine if needed for low output (β1 inotrope — increases contractility, caution if tachycardic). DOREMI: no significant outcome difference between milrinone and dobutamine. Milrinone (PDE3 inhibitor) alternative. ICU monitoring essential.
Key point
ICU: noradrenaline for hypotension; add dobutamine if low output persists. Adjust BP targets to perfusion. Discuss mechanical support if refractory.
Question 4 · Mechanical circulatory support
Correct answer: Urgent shock-team assessment for selected mechanical support, e.g. Impella or VA-ECMO, as a bridge to recovery or advanced therapy
Why
Mechanical support in refractory cardiogenic shock — shock-team selection:
- IABP: diastolic augmentation/afterload reduction; IABP-SHOCK II found no 30-day mortality benefit from routine use in MI-related shock.
- Impella: axial-flow pump, LV unloading. DanGer-Shock: lower 180-day mortality in selected STEMI-shock patients, but more adverse events; comatose survivors of out-of-hospital arrest were excluded.
- VA-ECMO: biventricular support. ECLS-SHOCK: routine early use in infarct-related shock did not reduce 30-day mortality and increased bleeding/vascular complications.
Key point
Refractory shock: call the shock/MCS team. Support is selected, not routine: IABP or VA-ECMO has no demonstrated routine mortality benefit in MI-related shock.
Question 5 · RV failure in cardiogenic shock
Correct answer: Avoid excess fluid; cautious small challenge only if underfilled. Support BP with noradrenaline and urgently treat the cause; discuss selective pulmonary vasodilators with ICU/PH specialists
Why
The RV is preload-sensitive but easily overloaded: assess filling before fluids. Noradrenaline supports systemic and RV coronary perfusion. Specialists may use inhaled nitric oxide or prostacyclin in selected cases. Sildenafil is not routine acute-shock treatment; pulmonary vasodilators need cause-specific selection and can worsen systemic hypotension. Treat PE with urgent reperfusion when indicated; RV infarction needs revascularisation. IABP does not directly support the RV.
Key point
RV shock: avoid fluid overload, support BP and treat the cause. Pulmonary vasodilators are specialist, cause-specific treatments.
Question 6 · Escalation decisions
Correct answer: Goals of care discussion — cardiogenic shock mortality very high in elderly with comorbidities. Discuss realistic expectations. DNACPR if appropriate. Balance aggressive treatment vs quality of life
Why
Cardiogenic shock: discuss goals of care. Advanced age, comorbidity and post-MI shock carry very high mortality even with full support.
- Explore the patient’s wishes and values if they have capacity; otherwise use best-interests/legal-proxy processes with those close to them. Age alone does not determine escalation.
- Discuss and document any DNACPR decision; document reasons if discussion would cause harm, not merely distress.
- Consider palliative-care input and comfort measures when appropriate.
Key point
Cardiogenic shock: always a goals-of-care conversation. Very high mortality. DNACPR if appropriate. Patient's values first.
Case complete
Practice on this page does not update your app progress. Open the browser app if you want its learning tools and progress record.